Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The involvement of Bcl-2 family proteins in AKT-regulated cell survival in cisplatin resistant epithelial ovarian cancer

7 Dec 2016

Abstract excerpt

// Yan Dai 1 , Shiguang Jin 2, 3 , Xueping Li 4 , Daxin Wang 2, 3 1 The Second Xiangya Hospital of Central South University, Changsha, China 2 Clinical Medical College, Yangzhou University, Yangzhou, China 3 Medical Research Centre, Northern Jiangsu People’s Hospital, Yangzhou, China 4 Nanjing Hospital Affiliated to Nanjing Medical University, The First Hospital of Nanjing, Nanjing, China Correspondence to: Daxin...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Mechanisms and Therapy
Share to Cell death mechanisms and regulation
Share to Ovarian cancer diagnosis and treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 27935869
DOI: 10.18632/oncotarget.13817

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The involvement of Bcl-2 family proteins in AKT-regulated cell survival in cisplatin resistant epithelial ovarian cancerPMID 27935869Read ↗

PI3K/AKT signaling pathway as a critical regulator of Cisplatin response in tumor cellsSemantic proximity Read ↗

Downregulation of AKT reverses platinum resistance of human ovarian cancers in vitroSemantic proximity Read ↗

Melatonin Sensitize the Ovarian Cancer Cells to Cisplatin through suppression of PI3K/Akt pathwaySemantic proximity Read ↗

Molecular alterations in apoptotic pathways after PKB/Akt-mediated chemoresistance in NCI H460 cellsSemantic proximity Read ↗

Molecular mechanisms of cisplatin resistance in ovarian cancerSemantic proximity Read ↗

SHCBP1 promotes cisplatin resistance of ovarian cancer through AKT/mTOR/Autophagy pathwaySemantic proximity Read ↗

Different Cytotoxic Effects of Cisplatin on Pancreatic Ductal Adenocarcinoma Cell LinesSemantic proximity Read ↗

Bcl‑2 family: Novel insight into individualized therapy for ovarian cancer (Review)Semantic proximity Read ↗

DNA-PK Mediates AKT Activation and Apoptosis Inhibition in Clinically Acquired Platinum ResistanceSemantic proximity Read ↗

p53 restoration can overcome cisplatin resistance through inhibition of Akt as well as induction of Bax.Semantic proximity Read ↗

Dual PI3K/mTOR inhibitor PKI-402 suppresses the growth of ovarian cancer cells by degradation of Mcl-1 through autophagy.Semantic proximity Read ↗

MK-2206 sensitizes BRCA-deficient epithelial ovarian adenocarcinoma to cisplatin and olaparib.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.